Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01830764 · ClinicalTrials.gov registry record · Phase 1
Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers
A Phase 1 study, sponsored by Dermira.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01830764: Completed Phase 1 study, sponsored by Dermira.
NCT01830764 is a Phase 1 study that has completed, run by Dermira. The registered enrollment target is 12 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01830764, a Phase 1 study, has completed, sponsored by Dermira.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is assess the safety and tolerability of lemuteporfin topical solution (LTS) with exposure to red light (PDT), when applied to the backs of healthy volunteers.
Primary Outcome
Adverse events and local tolerability assessed at pre and immediately post treatment, at Day 1 and Day 7 following treatment.
Interventions
- DRUG Red Light (PDT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
What the finished NCT01830764 record still lists
NCT01830764 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which Red Light (PDT) is the first listed.
NCT01830764 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01830764 about?
NCT01830764 is a clinical study titled "Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers". The purpose of this study is assess the safety and tolerability of lemuteporfin topical solution (LTS) with exposure to red light (PDT), when applied to the backs of healthy volunteers.
What is the current status of trial NCT01830764?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2013-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01830764?
The interventions under investigation include: Red Light (PDT) (DRUG).
Who is sponsoring clinical trial NCT01830764?
This trial is sponsored by Dermira, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01830764's enrollment target sits among peer trials
12 1852nd of 2000 higher than 90 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia